Prenatal developmental toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats

Regulatory Toxicology and Pharmacology

Volumn 40, Issue 1, 2004, Pages 1-8

  Wolterbeek, A P M ^a   Roberts, A ^b   Korte, H ^c   Unkila, M ^c   Waalkens Berendsen, D H ^a  

^a TNO   (Netherlands)

^b Cantox Health Sciences International   (Canada)

^c Hormos Nutraceutical Oy Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYMATAIRESINOL POTASSIUM ACETATE; ACETIC ACID DERIVATIVE; ENTEROLACTONE; LIGNAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS LUTEUM; DIET; DOSE RESPONSE; DRUG DOSE REGIMEN; FEMALE; FERTILITY; FETUS DEVELOPMENT; FETUS RESORPTION; FOOD INTAKE; GESTATION PERIOD; MALE; NONHUMAN; PALATABILITY; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; SEX RATIO; SKELETON MALFORMATION; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMAL FEED; ANIMALS; ANIMALS, OUTBRED STRAINS; CHEMISTRY, PHARMACEUTICAL; EATING; FEMALE; FETUS; LIGNANS; MALE; MATERNAL EXPOSURE; MOLECULAR STRUCTURE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; POTASSIUM ACETATE; PREGNANCY; RATS; REPRODUCTION; SEEDS; SESAMUM;

ANIMALIA; MAMMALIA; RATTUS NORVEGICUS;

EID: 3242703955     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2004.04.001     Document Type: Article

References (22)

1. Adlercreutz H., Hockerstedt K., Bannwart C., Bloigu S., Hamalainen E., Ollus A. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J. Steroid Biochem. 27:1987;1135-1144
2. Axelson M., Sjövall J., Gustafsson B.E., Setchell K.D.R. Origin of lignans in mammals and identification of a precursor in plants. Nature. 298:1982;659-660
3. Barrow M.V., Taylor J. A rapid method for detecting malformations in rat foetuses. J. Morphol. 127:1969;291-305
4. Dawson A.B. A note on the staining of the skeleton of cleared specimen with Alazarin Red S. Stain Technology. 1:1926;123-124
5. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 350:1997;990-994
6. Juhr N.C., Ladeburg M. Intestinal accumulation of urea in germ-free animals - factor in caecal enlargement. Lab. Anim. 20:1986;238-241
7. Lina, B.A.R., 2002. Sub-chronic (13-week) oral toxicity study with HM-3000 in rats. TNO report V4213
8. McCann S., Moysich K., Freudheim J., Ambrosone C., Shields P. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J. Nutr. 132:2002;3036-3041
9. OECD, 2001. Guideline for the Testing of Chemicals 414. Prenatal Developmental Toxicity Study, OECD, Paris
10. Oikarinen S., Pajari A.-M., Mutanen M. Chemopreventive activity of crude hydroxymatairesinol (HMR) extract in APCmin mice. Cancer Lett. 161:2000;253-258
11. Palmer A.K. The designs of subprimate animal studies. Wilson J.G., Fraser F.C. Handbook of Teratology. vol. IV:1978;215-253 Plenum Press, New York and London
12. Pietinen P., Stumpf K., Männistö S., Kataja V., Uusitupa M., Adlercreutz H. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol. Biomarkers. Prev. 10:2001;339-344
13. Saarinen N.M., Wärri A., Mäkalä S.I., Eckerman C., Reunanen M., Ahotupa M., Salmi S.M., Franke A.A., Kangas L., Santti R. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr. Cancer Res. 36:2000;207-216
14. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut Suppl. 1:1994;S35-S38
15. Schöttner M., Spiteller G. Lignans interfering with 5-alpha-dihydrotestosterone binding to human sex hormone-binding globulin. J. Nat. Prod. 61:1998;119-121
16. Vanharanta M., Voutilainen S., Lakka T.A., van der Lee M., Aldercreutz H., Salonen J.T. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet. 354:1999;2112-2115
17. Vanharanta M., Voutilainen S., Nurmi T., Kaikkonen J., Roberts L.J., Morrow J.D., Aldercreutz H., Salonen J.T. Association between low serum enterolactone and increased plasma F2 isoprostanes, a measure of lipid peroxidation. Atherosclerosis. 160:1999;465-469
18. Vanharanta M., Voutilainen S., Nurmi T., Kaikkonen J., Roberts J., Morrow J.D., Adlercreutz H., Salonen J.T. Association between low serum enterolactone and increased plasma F2-isoprostane, a measure of lipid peroxidation. Artherosclerosis. 160:2002;465-469
19. Wang I. Mammalian phytoestrogens: enterodiol and enterolactone. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 777:2002;289
20. World Health Organisation (WHO), 1987. Principles for the Safety Assessment of Food Additives and Contaminants in Food. 47 (see also p. 82)
21. Wilson J.F. Severe reduction in food intake by pregnant rats resembles a learned food aversion. Physiol. Behav. 41:1987;291-295
22. Wilson J.F. Effect of pregnancy, sucrose, and various low-protein diets on the eating behaviour of rats. Physiol. Behav. 62:1997;779-782